Approved and signed investments
In 2025, BIO approved a record €235 M in development impact investments, across 30 impactful projects in Africa, South-East Asia, Latin-America and Ukraine.
In total, BIO has now committed €1,200 M in development impact investments in 171 projects, meaning an increase of 10% from the previous year. This also means the highest amount of net approval since 2019.
In total, BIO now has €1,033 M in signed investments.
BIO has granted a EUR 1.5 M loan to ACEP Group, a pan-African microfinance institution operating in Burkina Faso, Niger, Madagascar and Cameroon.
BIO has invested USD 15 M in equity in Adenia Entrepreneurial Fund II, a sector-agnostic SME fund focused on founder/family-led companies across Africa
BIO has granted a USD 15 M loan to Amartha, an Indonesian microfinance fintech platform.
BIO has granted a USD 15M loan to Banco Atlántida El Salvador (BAES), specialized on SME financing in the Salvadorian market.
BIO has granted a USD 15 M loan to Banco Multiple ADEMI, a Dominican multiple bank with a strong focus on MSME financing
BIO has invested an additional USD 1.5 M in equity in Banco Popular, a Honduran microfinance institution.
BIO has granted a USD 15M loan to Bandwidth and Cloud Services, an optic fiber network owner operating across seven markets in sub-Saharan Africa.
BIO has invested EU 20M in equity in Coris Holding, a leading and top performing banking group in Francophone West Africa.
BIO has granted a USD 10 M loan to ECOM Agroindustrial, one of the largest merchant of coffee, cocoa, cotton, nuts - worldwide.
BIO has invested USD 15 M in Excelsior Capital Vietnam Partners II, a second-generation fund targeting Vietnamese established, larger SMEs and mid-sized businesses
BIO has granted a follow-on investment of €2 million in the FEFISOL 2 fund. Through its services, the fund contributes to the financial inclusion of vulnerable groups (rural communities, women, young people and smallholder farmers) and small businesses in Africa, as well as to a fair and sustainable agricultural sector
BIO has granted a EUR 3 M loan to Foods'Co, an Ivorian food processing company.
BIO has granted a EUR 8M loan to Glacier Products Ltd, a family-owned Kenyan dairy company that
manufactures, sells and distributes a wide range of dairy products including ice-cream, chocolate and
yogurt.
BIO has invested USD 10 M in equity in Helios CLEAR Fund SCSp, a climate fund dedicated to securing a low-carbon growth trajectory for Africa.
BIO has invested EUR 2 M in Equity in Kampani, an impact-first Investment Fund aiming to improve the livelihood
conditions of farmers families and their communities through supporting entrepreneurial smallholder
farming.
BIO has invested USD 10M in equity in LMFCF2, an open-ended private credit fund with the objective of providing loans to fintech companies financing MSMEs in emerging markets.
BIO has granted a € 2 M loan to Limbua Group, a Kenyan company active in the sourcing, processing and distribution of macadamia nuts, mango and avocado.
BIO has invested EUR 10 M in equity in Orchidia Pharmaceutical Industries, the leading Egyptian developer and manufacturer of own branded pharmaceuticals generics specialized in the ophthalmic segment.
BIO has granted a USD 3.7 M loan to Super Silica Bangladesh Limited, a local family-owned manufacturing SME that is the first producer of Green Precipitated Silica in Bangladesh.
BIO has provided a €3 M loan to Vital Finance Benin, one of the country's leading microfinance institutions.